WTT Investment: Funding, Team & Investors | Startup Intros

Loading organizations...

WTT Investment: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 1, 2024	NextPoint Therapeutics	$43.0M Series B	Jacob Vogelstein	ARCH Venture Partners, Atlas Venture, Catalio Capital, MPM Capital, Polaris Partners, Gordon Freeman, Arkin Bio Ventures, Binney Street Capital, Invus, Leaps by Bayer, Sanofi Ventures, Sixty Degree Capital
Jan 3, 2024	Remix Therapeutics	$60.0M Other Equity	Peter Svennilson	Alexandria Venture Investments, ARCH Venture Partners, Atlas Venture, Casdin Capital, Foresite Capital, Surveyor Capital, Willett Advisors
Sep 1, 2021	Allay Therapeutics	$60.0M Series C	Arboretum Ventures	Lightstone Ventures, New Enterprise Associates (NEA), Tak Cheung, New Enterprise Associates, Brandon Capital, NEA, Pavilion Capital, Temasek, Vertex Growth, Vertex Ventures HC
Oct 1, 2020	MycoWorks	$45.0M Series B	Kiersten Stead, WTT Investment	Amazon Climate Pledge Fund, Anorak Ventures, Breakthrough Energy Ventures, ENIAC Ventures, Fifty Years, Founders Fund, F-Prime Capital Partners, Future Shape, Intuition Capital, Mayfield, Pioneer Fund, Prelude Ventures, SeaX Ventures, Social Impact Capital, SOSV, VSC Ventures, Bradley Horowitz, Peter Carlsson, Reshma Saujani, John Legend, natalie portman, Tony Fadell, 8VC, AgFunder, Gruss & Co., Humboldt Fund, Novo Holdings, Valor Equity Partners, Wireframe Ventures
Jul 1, 2020	Geltor	$91.0M Series B	Costa Yiannoulis	Hatteras Venture Partners, Mayfield, Morpheus Ventures, SOSV, Synthesis Capital, Wilbur-Ellis [Cavallo], ADM, Blue Horizon, Cultivian Sandbox Ventures, GELITA, Humboldt Fund, iSelect Fund, Pegasus Tech Ventures, RIT Capital Partners
Jan 3, 2017	Ascletis	$100.6M Series B	C-Bridge Capital	FOCUS Media Jiangnanchun Foundation, Goldman Sachs, Tasly Pharmaceutical